AIxMed
AIxMed, Inc. offers an AI-powered digital cytology platform designed to enhance cancer diagnosis and monitoring. Their solutions, such as AIxURO for urine cytology (bladder cancer), aim to improve workflow efficiency, accuracy, and patient care. The platform combines whole slide imaging (WSI), qualitative morphology, and quantitative metrics to assist pathologists. Key benefits include faster analysis, reduced turnaround times, and improved diagnostic confidence by minimizing guesswork in cell identification and characterization. AIxMed targets common cancers like bladder, thyroid, cervical, and lung cancer with their specialized AI modules, providing data-driven pathology to benefit patients, providers, and payors by supporting earlier detection and more personalized treatment.
AIxMed
AIxMed, Inc. offers an AI-powered digital cytology platform designed to enhance cancer diagnosis and monitoring. Their solutions, such as AIxURO for urine cytology (bladder cancer), aim to improve workflow efficiency, accuracy, and patient care. The platform combines whole slide imaging (WSI), qualitative morphology, and quantitative metrics to assist pathologists. Key benefits include faster analysis, reduced turnaround times, and improved diagnostic confidence by minimizing guesswork in cell identification and characterization. AIxMed targets common cancers like bladder, thyroid, cervical, and lung cancer with their specialized AI modules, providing data-driven pathology to benefit patients, providers, and payors by supporting earlier detection and more personalized treatment.